MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income
$265,238K
Depreciation and
amortization
$64,841K
Decrease/(increase) in other assets
-$36,835K
Stock option expense
$32,671K
Increase in other
liabilities
$10,424K
Noncash portion of
long-term incentive...
$4,886K
Litigation settlements
$1,425K
Noncash directors'
compensation
$1,123K
Decrease/(increase) in inventories
-$650K
Other sources
$459K
Amortization of debt issuance
costs
$321K
Net cash provided by
operating activities
$388,272K
Canceled cashflow
$30,601K
(decrease)/increase in cash and cash
equivalents
-$103,835K
Canceled cashflow
$388,272K
Proceeds from exercise of
stock options
$27,152K
Change in cash
overdraft payable
$10,970K
Other sources/(uses)
$1,125K
Proceeds from sale of
fixed assets
$4,568K
(increase)/decrease in accounts
receivable
$11,596K
Change in current
income taxes
-$6,217K
Benefit for deferred
income taxes
-$5,944K
Decrease in accounts
payable and other...
-$5,194K
(increase)/decrease in prepaid
expenses
$844K
Net change in lease
assets and liabilities
$806K
Net cash used by
financing activities
-$432,767K
Canceled cashflow
$39,247K
Net cash used by
investing activities
-$59,340K
Canceled cashflow
$4,568K
Purchases of treasury
stock
$431,500K
Dividends paid
$31,695K
Capital stock
surrendered to pay taxes on...
$8,819K
Capital expenditures
$62,795K
Other uses
$888K
Business combinations,
net of cash acquired
$225K
Back
Back
Cash Flow
source: myfinsight.com
CHEMED CORP (CHE)
CHEMED CORP (CHE)